background
acut
respiratori
infect
lead
caus
infecti
diseaserel
morbid
hospitalis
mortal
among
children
worldwid
particularli
develop
countri
lowincom
countri
patient
acut
respiratori
infect
ari
whether
mild
sever
still
treat
empir
aim
studi
evalu
risk
factor
associ
evolut
outcom
respiratori
ill
patient
age
year
old
conduct
prospect
studi
paediatr
ward
antananarivo
novemb
juli
includ
patient
year
old
suffer
respiratori
infect
collect
demograph
socioeconom
clinic
epidemiolog
data
sampl
laboratori
analysi
death
rapid
progress
respiratori
distress
hospitalis
hospitalis
day
consid
sever
outcom
use
multivari
analysi
studi
effect
coinfect
respiratori
infect
major
caus
infecti
diseaserel
morbid
hospitalis
mortal
among
children
year
old
worldwid
particularli
develop
countri
diseas
respons
million
death
worldwid
everi
year
thu
among
lead
caus
death
common
infecti
caus
death
although
mani
episod
respiratori
infect
mild
percent
sever
enough
warrant
hospitalis
diseas
respons
least
world
disabl
death
estim
million
case
respiratori
infect
annual
among
african
children
longitudin
studi
suggest
overal
mortal
rate
among
children
develop
countri
despit
respiratori
infect
public
health
prioriti
data
epidemiolog
africa
spars
diagnost
method
identifi
pathogen
rapidli
avail
lowincom
set
patient
respiratori
infect
treat
empir
antibiot
base
local
epidemiolog
administ
appropri
therapi
appropri
time
would
improv
outcom
diseas
also
econom
impact
lead
substanti
consumpt
antimicrobi
agent
commun
hospit
set
furthermor
high
frequenc
respiratori
infect
excess
use
antimicrobi
agent
major
contributor
develop
antibioticresist
pathogen
know
local
epidemiolog
respiratori
infect
essenti
appropri
empir
therapi
prescrib
evalu
mix
infect
rel
import
potenti
pathogen
may
also
contribut
improv
understand
pathogenesi
infect
studi
aim
evalu
risk
factor
associ
evolut
outcom
respiratori
ill
patient
age
year
old
hospitalis
one
four
main
public
hospit
antananarivo
studi
conduct
centr
hospitali
de
soavinandriana
cenhosoa
antananarivo
capit
citi
madagascar
locat
central
highland
antananarivo
consist
administr
commerci
industri
residenti
area
patch
agricultur
land
mostli
rice
field
citi
divid
six
administr
district
madagascar
hib
vaccin
introduc
pneumococcia
vaccin
cenhosoa
nation
referr
hospit
third
district
urban
municip
antananarivo
hospit
care
hospit
paid
patient
locat
near
institut
pasteur
madagascar
ipm
paediatr
neonatolog
ward
cenhosoa
bed
annual
number
children
hospit
respiratori
infect
estim
prospect
hospitalbas
studi
conduct
cenhosoa
novemb
juli
case
definit
elig
criteria
use
studi
describ
figur
demograph
socioeconom
clinic
epidemiolog
data
record
case
report
form
crf
paediatrician
complet
crf
valid
clinic
research
offic
instruct
sheet
provid
clinic
research
offic
ensur
accur
data
collect
data
collect
manag
senior
medic
epidemiologist
admiss
train
personnel
use
standard
oper
procedur
collect
nasal
throat
swab
sputum
sampl
aspir
airway
secret
hypopharynx
nose
tracheal
aspir
nasopharyng
secret
tracheal
aspir
sputum
obtain
start
antibiot
therapi
specimen
transport
within
minut
sampl
ipm
test
respiratori
pathogen
hiv
serostatu
determin
preval
hiv
madagascar
low
estim
around
per
studi
approv
nation
ethic
committe
ministri
health
madagascar
written
inform
consent
obtain
parent
legal
guardian
children
enrol
studi
consent
enrol
studi
requir
consent
provid
sampl
diagnosi
influenza
respiratori
pathogen
fill
case
report
form
crf
refus
consent
hospit
within
two
week
consult
reason
exclus
studi
virolog
analys
perform
nation
influenza
centr
nic
panel
multiplex
realtim
rtpcr
use
detect
viral
pathogen
nasopharyng
swab
primer
probe
obtain
author
report
studi
develop
nic
viral
rna
dna
extract
ml
specimen
use
qiaamp
viral
rna
mini
kit
qiaampminelut
viru
kit
qiagen
courtaboeuf
franc
accord
manufactur
protocol
abi
fast
realtim
pcr
system
appli
biosystem
use
amplif
sampl
subject
five
differ
amplif
reaction
contain
primer
probe
specif
two
three
virus
follow
respiratori
virus
target
previous
describ
parainfluenza
viru
piv
human
coronavirus
hcov
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
human
rhinoviru
hrv
adenoviru
adv
bocaviru
bov
part
routin
influenza
surveil
screen
influenza
virus
perform
mdck
cell
inocul
realtim
rtpcr
accord
cdc
protocol
bacteriolog
analys
perform
medic
analysi
laboratori
ipm
gramstain
sputum
prepar
examin
polynuclear
neutrophil
pn
epitheli
cell
area
maxim
purul
examin
grade
follow
class
cell
fewer
pn
class
cell
pn
class
cell
pn
class
cell
pn
class
fewer
cell
pn
class
present
high
posit
predict
valu
laboratori
determin
sampl
oral
origin
reject
class
consid
reject
criteria
quantit
sputum
cultur
perform
specimen
previous
describ
method
sputum
specimen
homogen
equal
volum
digesteurh
vortex
mixer
ml
aliquot
homogen
serial
dilut
salin
ml
aliquot
dilut
plate
steril
inocul
blood
columbia
agar
nalidix
acid
colistin
anc
chocol
polyvitex
pvx
agar
drigalski
agar
plate
incub
co
hour
coloni
grow
plate
inocul
suitabl
dilut
count
enumer
bacteri
speci
present
threshold
signific
set
ml
one
two
speci
isol
identifi
standard
laboratori
method
monoinfect
defin
presenc
one
pathogen
determin
viral
bacteri
analysi
patient
one
pathogen
detect
consid
coinfect
outcom
score
sever
patient
die
present
wrong
clinic
evolut
hospitalis
complic
hospit
longer
day
rd
quartil
analys
perform
r
softwar
nonparametr
wilcoxon
test
use
compar
mean
qualit
variabl
compar
fisher
exact
test
statist
differ
consid
signific
multivari
backward
stepbystep
logist
regress
perform
take
account
confound
bia
interact
involv
pathogen
link
depend
variabl
variabl
includ
initi
model
five
age
group
defin
analysi
month
month
month
month
month
month
novemb
juli
children
recruit
hospit
patient
elig
eleven
elig
patient
refus
particip
studi
differ
includ
patient
age
sex
diagnosi
admiss
baselin
demograph
clinic
characterist
patient
shown
tabl
sex
ratio
malefemal
mean
age
year
ci
age
rang
day
year
patient
year
old
younger
diagnos
admiss
tabl
significantli
differ
age
group
bronchiol
found
frequent
among
patient
month
old
ltri
pneumonia
frequent
among
patient
age
month
respect
fortynin
patient
least
one
underli
diseas
asthma
frequent
children
underli
condit
particularli
atopi
passiv
exposur
tobacco
smoke
seventyon
hospit
previou
month
patient
age
month
significantli
prior
hospitalis
p
differ
sex
statist
signific
around
patient
treat
antibiot
hospitalis
tabl
significantli
patient
month
old
receiv
antibiot
treatment
hospitalis
differ
sex
statist
signific
frequenc
bacteri
detect
lower
group
prior
antibiot
treatment
versu
p
relationship
found
viral
result
accur
inform
immunis
avail
vaccin
card
children
eightyseven
percent
children
complet
vaccin
bcg
receiv
one
haemophilu
influenza
type
b
vaccin
child
vaccin
streptococcu
pneumonia
two
vaccin
influenza
averag
durat
hospitalis
day
ci
rang
day
median
durat
hospitalis
day
patient
hospitalis
day
durat
hospitalis
live
patient
day
fatal
case
signific
differ
sex
age
group
discharg
inform
avail
case
patient
fulli
recov
without
complic
hospit
stay
condit
children
worsen
hospitalis
nine
patient
die
death
children
month
age
six
children
less
month
old
patient
die
streptococcu
pneumonia
pathogen
frequent
detect
follow
rsv
influenza
type
viru
multivari
analysi
factor
possibl
associ
coinfect
sex
age
group
number
room
home
antibiot
treatment
hospitalis
includ
initi
model
multivari
analysi
indic
children
month
age
often
infect
one
pathogen
differ
statist
signific
month
old
group
adjust
tabl
previou
antibiot
treatment
hospit
significantli
protect
factor
coinfect
univari
analysi
influenza
rhinoviru
streptococcu
pneumonia
haemophilu
influenza
type
b
significantli
associ
coinfect
haemophilu
influenza
pneumo
niae
often
associ
coinfect
adjust
respect
tabl
univari
analysi
show
sever
outcom
significantli
frequent
patient
comorbid
includ
prematur
congenit
diseas
heart
diseas
cerebr
malform
also
two
three
patient
present
malnutrit
die
hospit
month
prior
admiss
also
associ
sever
outcom
low
household
incom
less
us
less
us
us
associ
sever
outcom
multivari
analysi
age
group
monthli
household
incom
admiss
diagnosi
comorbid
previou
hospitalis
infect
influenza
viru
type
rsv
rhinoviru
includ
initi
model
multivari
analysi
tabl
adjust
variabl
show
age
month
live
household
low
incom
presenc
comorbid
significantli
aggrav
factor
infect
influenza
type
viru
significantli
protect
factor
sever
outcom
ci
paediatr
ward
cenhosoa
children
month
hospitalis
respiratori
infect
coinfect
frequent
encount
pathogen
h
influenza
pneumonia
influenza
rhinovirus
hospitalis
evolut
respiratori
infect
wors
youngest
children
present
comorbid
live
lowincom
household
viral
infect
made
larg
contribut
burden
infecti
respiratori
diseas
viral
pathogen
found
patient
bacteri
pathogen
although
patient
treat
antibiot
hospitalis
presum
affect
observ
preval
bacteri
infect
find
virus
similar
studi
exampl
detect
rate
viral
pathogen
studi
vietnam
studi
mozambiqu
focus
hospitalis
children
result
consist
paediatr
ward
cenhosoa
find
also
consist
anoth
report
madagascar
indic
rsv
influenza
frequent
viral
caus
commun
respiratori
infect
studi
develop
countri
address
role
bacteri
coinfect
sever
respiratori
ill
focu
viral
aetiolog
molecular
diagnosi
tool
avail
pathogen
allow
identifi
infect
case
develop
countri
laboratori
method
identifi
bacteri
pathogen
difficult
implement
lack
appropri
facil
materi
hospit
laboratori
long
transit
time
prejudici
stabil
specimen
studi
transit
time
reduc
proxim
cenhosoa
ipm
unfortun
find
rate
bacteri
infect
may
artifici
low
due
prior
antibiot
use
studi
streptococcu
pneumonia
common
bacteri
pathogen
studi
hospitalis
patient
acut
respiratori
ill
haemophilu
influenza
type
b
next
frequent
primari
infect
respiratori
viru
increas
risk
secondari
bacteri
pneumonia
viral
bacteri
coinfect
common
young
children
pneumonia
develop
countri
episod
evid
probabl
mix
viralbacteri
infect
record
case
commun
acquir
pneumonia
children
larg
proport
patient
coinfect
month
age
group
highest
risk
result
consist
studi
patient
commun
respiratori
infect
madagascar
viral
bacteri
coinfect
found
patient
frequent
combin
streptococcu
pneumonia
one
sever
respiratori
virus
data
gambia
nigeria
indic
mix
bacteri
viral
infect
may
occur
case
childhood
pneumonia
recent
data
south
africa
indic
least
case
viralassoci
pneumonia
may
due
concurr
infect
streptococcu
pneumonia
absenc
vaccin
pneumococc
conjug
vaccin
appropri
manag
respiratori
infect
signific
impact
child
mortal
import
target
prioriti
group
children
risk
die
group
includ
young
infant
children
infect
hiv
malnourish
children
studi
outcom
sever
children
present
malnutrit
die
chisti
et
al
show
combin
pneumonia
sever
moder
malnutrit
associ
high
risk
death
rr
rang
sever
malnutrit
moder
malnutrit
moder
malnutrit
rr
sever
studi
also
lead
result
ballard
et
al
report
malnutrit
level
parent
educ
impact
incid
respiratori
infect
pneumonia
lead
caus
childhood
mortal
respons
approxim
death
african
children
five
year
age
year
howev
littl
inform
avail
caus
childhood
pneumonia
develop
countri
studi
patient
die
valu
low
note
studi
popul
consist
patient
famili
socioeconom
level
averag
gener
popul
madagascar
patient
die
frequent
coinfect
month
old
result
consist
studi
topic
develop
countri
howev
studi
design
may
impact
mortal
rate
observ
inde
fee
hospitalis
paid
studi
allow
followup
optimis
studi
identifi
live
lowincom
household
risk
factor
sever
outcom
import
patient
manag
hospitalis
also
highlight
consequ
financi
barrier
access
vaccin
influenza
pneumococci
vaccin
includ
panel
vaccin
expand
programm
immunis
epi
period
madagascar
avail
privat
centr
expens
therefor
inaccess
much
popul
two
patient
includ
studi
receiv
vaccin
influenza
none
receiv
vaccin
pneumococci
accord
vaccin
card
statist
analysi
identifi
influenza
infect
protect
factor
fatal
outcom
howev
wellknown
influenza
may
impact
high
mortal
major
epidem
cocircul
influenza
viru
rsv
high
frequenc
streptococcu
pneumonia
coinfect
children
age
less
year
rais
issu
indirect
impact
influenza
vaccin
respiratori
infect
particular
benefit
establish
system
vaccin
infecti
agent
vaccin
avail
consid
provid
access
larger
proport
popul
conclus
advoc
research
develop
countri
document
detail
impact
viral
bacteri
coinfect
prognosi
sever
respiratori
ill
numer
infect
found
studi
could
avoid
immunis
recommend
appropri
vaccin
must
rapidli
avail
malagasi
children
would
reduc
mortal
among
youngest
children
age
group
current
suffer
greatest
burden
morbid
mortal
associ
respiratori
infect
tabl
diagnosi
admiss
accord
age
group
docx
